Examining internet-delivered cognitive behaviour therapy for patients with chronic kidney disease on haemodialysis: A feasibility open trial

Journal of Psychosomatic Research

Volumn 89, Issue , 2016, Pages 78-84

  Chan, Ramony ^a,b   Dear, Blake F ^c   Titov, Nick ^c   Chow, Josephine ^d,e,f   Suranyi, Michael ^a,b,g  

^a LIVERPOOL HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c MACQUARIE UNIVERSITY   (Australia)

^d SOUTH WESTERN SYDNEY LOCAL HEALTH DISTRICT   (Australia)

^e UNIVERSITY OF SYDNEY   (Australia)

^f UNIVERSITY OF TASMANIA   (Australia)

^g UNIVERSITY OF WESTERN SYDNEY   (Australia)

Author keywords

Anxiety; Chronic; Clinical trial; Cognitive behaviour therapy; Depression; Internet based intervention; Kidney disease related loss; Kidney failure; Mental health; Psychological adaptation; Renal dialysis

Indexed keywords

ADULT; AGED; ANXIETY; ARTICLE; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE BEHAVIORAL THERAPY; DEPRESSION; DISABILITY; DISTRESS SYNDROME; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; INTERNET; KIDNEY DISEASE; MALE; PATIENT SATISFACTION; QUALITY OF LIFE; TREATMENT OUTCOME; AUSTRALIA; COGNITIVE THERAPY; COMPUTER ASSISTED THERAPY; FEASIBILITY STUDY; MIDDLE AGED; PROCEDURES; PSYCHOLOGY; RENAL INSUFFICIENCY, CHRONIC; TRENDS;

ADULT; AGED; ANXIETY; AUSTRALIA; COGNITIVE THERAPY; DEPRESSION; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERNET; MALE; MIDDLE AGED; QUALITY OF LIFE; RENAL DIALYSIS; RENAL INSUFFICIENCY, CHRONIC; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 84985994385     PISSN: 00223999     EISSN: 18791360     Source Type: Journal    
DOI: 10.1016/j.jpsychores.2016.08.012     Document Type: Article

References (49)

1. [1] Begg, S., Vos, T., Barker, B., Stevenson, C., Stanley, L., Lopez, A.D., The Burden of Disease and Injury in Australia 2003. Cat. No. PHE 82. 2007, Canberra, AIHW.
2. [2] Palmer, S.C., Vecchio, M., Craig, J.C., Tonelli, M., Johnson, D.W., Nicolucci, A., et al. Association between depression and death in people with CKD: a meta-analysis of cohort studies. Am. J. Kidney Dis. 62:3 (2013), 493–505.
3. [3] Kaptein, A.A., van Dijk, S., Broadbent, E., Falzon, L., Thong, M., Dekker, F.W., Behavioural research in patients with end-stage renal disease: a review and research agenda. Patient Educ. Couns. 81:1 (2010), 23–29.
4. [4] Chan, R., Steel, Z., Brooks, R., Heung, T., Erlich, J., Chow, J., et al. Psychosocial risk and protective factors for depression in the dialysis population: a systematic review and meta-regression analysis. J. Psychosom. Res. 71:5 (2011), 300–310.
5. [5] Palmer, S.C., Vecchio, M., Craig, J.C., Tonelli, M., Johnson, D.W., Nicolucci, A., et al. Prevalence of depression in chronic kidney disease: systematic review and meta-analysis of observational studies. Kidney Int. 84 (2013), 179–191.
6. [6] Chilcot, J., Norton, S., Wellsted, D., Davenport, A., Firth, J., Farrington, K., Distinct depression symptom trajectories over the first year of dialysis: associations with illness perceptions. Ann. Behav. Med. 45:1 (2012), 78–88.
7. [7] Ng, H.J., Tan, W.J., Mooppil, N., Newman, S., Griva, K., Prevalence and patterns of depression and anxiety in hemodialysis patients: a 12-month prospective study on incident and prevalent populations. Br. J. Health Psychol. 20:2 (2015), 374–395.
8. [8] Kimmel, P.L., Cukor, D., Cohen, S.D., Peterson, R.A., Depression in end-stage renal disease patients: a critical review. Adv. Chronic Kidney Dis. 14:4 (2007), 328–334.
9. [9] Chilcot, J., Wellsted, D., Farrington, K., Depression in end-stage renal disease: current advances and research. Semin. Dial. 23:1 (2009), 74–82.
10. [10] Christensen, A.J., Van Liew, J.R., Kellerman, Q.D., Depression in chronic kidney disease: a context for comorbidity. Richards, C.S., O'Hara, M.W., (eds.) The Oxford Handbook of Depression and Comorbidity, 2014, Oxford University Press, Oxford, 398–410.
11. [11] Chan, R., Brooks, R., Erlich, J., Chow, J., Suranyi, M., The effects of kidney-disease-related loss on long-term dialysis patients' depression and quality of life: positive affect as a mediator. Clin. J. Am. Soc. Nephrol. 4:1 (2009), 160–167.
12. [12] Chan, R., Brooks, R., Erlich, J., Gallagher, M., Snelling, P., Chow, J., et al. Studying psychosocial adaptation to End-Stage Renal Disease: the proximal-distal model of health-related outcomes as a base model. J. Psychosom. Res. 70:5 (2011), 455–464.
13. [13] Murtagh, F.E.M., Addington-Hall, J., Higginson, I.J., The prevalence of symptoms in end-stage renal disease: a systematic review. Adv. Chronic Kidney Dis. 14:1 (2007), 82–99.
14. [14] Cukor, D., Ver Halen, N., Fruchter, Y., Anxiety and quality of life in ESRD. Semin. Dial. 26:3 (2013), 265–268.
15. [15] Finkelstein, F.O., Watnick, S., Finkelstein, S.H., Wuerth, D., The treatment of depression in patients maintained on dialysis. J. Psychosom. Res. 53:4 (2002), 957–960.
16. [16] Hedayati, S.S., Yalamanchili, V., Finkelstein, F.O., A practical approach to the treatment of depression in patients with chronic kidney disease and end-stage renal disease. Kidney Int. 81:3 (2012), 247–255.
17. [17] Finkelstein, F.O., Finkelstein, S.H., Depression in chronic dialysis patients: assessment and treatment. Nephrol. Dial. Transplant. 15:12 (2000), 1911–1913.
18. [18] Cohen, L.M., Tessier, E.G., Germain, M.J., Levy, N.B., Update on psychotropic medication use in renal disease. Psychosomatics 45:1 (2004), 34–48.
19. [19] Hedayati, S.S., Finkelstein, F.O., Epidemiology, diagnosis, and management of depression in patients with CKD. Am. J. Kidney Dis. 54 (2009), 741–752.
20. [20] Duarte, P.S., Miyazaki, M.C., Blay, S.L., Sesso, R., Cognitive-behavioral group therapy is an effective treatment for major depression in hemodialysis patients. Kidney Int. 76 (2009), 414–421.
21. [21] Cukor, D., Ver Halen, N., Asher, D.R., Coplan, J., Weedon, J., Wyka, K.E., et al. Psychosocial intervention improves depression, quality of life, and fluid adherence in hemodialysis. J. Am. Soc. Nephrol. 25 (2014), 196–206.
22. [22] Titov, N., Internet-delivered psychotherapy for depression in adults. Curr. Opin. Psychiatry 24:1 (2011), 18–23.
23. [23] Titov, N., Dear, B.F., Bennett-Levy, J., Klein, D., Rapee, R.M., Shann, C., The MindSpotClinic: an accessible, efficient and effective online treatent service for anxiety and depression. Psychiatr. Serv. 66:10 (2015), 1043–1050.
24. [24] Andersson, G., Titov, N., Advantages and limitations of Internet-based interventions for common mental disorders. World Psychiatry 13:1 (2014), 4–11.
25. [25] Andersson, G., Cuijpers, P., Internet-based and other computerized psychological treatments for adult depression: a meta-analysis. Cognitive Behavior Therapy 38:4 (2009), 196–205.
26. [26] Perini, S., Titov, N., Andrews, G., Clinician-assisted internet-based treatment is effective for depression: randomized controlled trial. Aust. N. Z. J. Psychiatry 43 (2009), 571–578.
27. [27] Titov, N., Andrews, G., Davies, M., McIntyre, K., Robinson, E., Solley, K., Internet treatment for depression: a randomized controlled trial comparing clinician vs. technician assistance. PLoS ONE, 5(6), 2010, e10939.
28. [28] Dear, B.F., Gandy, M., Karin, E., Staples, L., Johnston, L., Fogliati, V., et al. The Pain Course: a randomised controlled trial examining an internet delivered pain management program when provided with different levels of clinician support. Pain 156 (2015), 1920–1935.
29. [29] Dear, B.F., Titov, N., Nicholson Perry, K., Johnston, L., Wootton, B.M., Terides, M.D., et al. The Pain Course: a randomised controlled trial of clinician-guided internet-delivered cognitive behaviour therapy program for managing chronic pain and emotional wellbeing. Pain 154 (2013), 942–950.
30. [30] Mohr, D.C., Lovera, J., Brown, T., Cohen, B., Neylan, T., Henry, R., et al. A randomized trial of stress management for the prevention of new brain lesions in MS. Neurology 79:5 (2012), 412–419.
31. [31] Alberts, N.M., Hadjistavropoulos, H.D., Dear, B.F., Titov, N., Transdiagnostic internet-delivered cognitive behaviour therapy for cancer survivors in the re-entry phase: a feasibility trial. Psycho-Oncology, 2015.
32. [32] Kroenke, K., Spitzer, R.L., Williams, J.B.W., The PHQ-9: validity of a brief depression severity measure. J. Gen. Intern. Med. 16:9 (2001), 606–613.
33. [33] Kroenke, K., Spitzer, R.L., Williams, J.B.W., Lowe, B., The patient health questionnaire somatic, anxiety, and depressive symptom scales: a systematic review. Gen. Hosp. Psychiatry 32 (2010), 345–359.
34. [34] Dear, B.F., Titov, N., Sunderland, M., McMillan, D., Anderson, T., Lorian, C., et al. Psychometric comparison of the Generalized Anxiety Disorder Scale - 7 and the Penn State Worry Questionnaire for measuring response during treatment of generalised anxiety disorder. Cognitive Behavior Therapy 40 (2011), 216–227.
35. [35] Kroenke, K., Spitzer, R.L., Williams, J.B.W., Monahan, P.O., Lowe, B., Anxiety disorders in primary care: prevalence, impairment, comorbidity, and detection. Ann. Intern. Med. 146 (2007), 317–325.
36. [36] Kessler, R.C., Andrews, G., Colpe, L.J., Hiripi, E., Mroczek, D.K., Normand, S.-L.T., et al. Short screening scales to monitor population prevalences and trends in non-specific psychological distress. Psychol. Med. 32:6 (2002), 959–976.
37. [37] Sheehan, D.V., The Anxiety Disease. 1983, Scribner, New York.
38. @ Health Survey (With a Supplement Documenting Version 1). 2002, QualityMetric Incorporated, Lincoln, RI.
39. [39] Chan, R., Brooks, R., Gallagher, M., Erlich, J., Snelling, P., Chow, J., et al. Measuring kidney-disease-related loss in the samples of pre-dialysis and dialysis patients: validating the kidney disease loss scale. Clin. J. Am. Soc. Nephrol. 5 (2010), 1249–1254.
40. [40] Hays, R.D., Kallich, J.D., Mapes, D.L., Coons, S.J., Amin, N., Carter, W.B., et al. Kidney Disease Quality of Life Short Form (KDQOL-SF), Version 1.3: A Manual for Use and Scoring. 1997, RAND, Santa Monica, CA (P-7928).
41. [41] Sheehan, D.V., Lecrubier, Y., Sheehan, K.H., Amorim, P., Janavs, J., Weiller, E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J. Clin. Psychiatry 59:Suppl. 20 (1998), 22–33.
42. [42] WH Organization, Composite International Diagnostic Interview, Version 1.0. 1990, World Health Organization, Geneva.
43. [43] Titov, N., Dear, B.F., Johnson, L., Lorian, C., Zou, J., Wootton, B.M., et al. Improving adherence and clinical outcomes in self-guided internet treatment for anxiety and depression: randomised controlled trial. PLoS One, 8(7), 2013, e62873, 10.1371/journal.pone.0062873.
44. [44] Hubbard, A.E., Ahern, J., Fleischer, N.L., Van der Laan, M., Lippman, S.A., Jewell, N., et al. To GEE or not to GEE: comparing population average and mixed models for estimating the associations between neighorhood risk factors and health. Epidemiology 21:4 (2010), 467–474.
45. [45] Titov, N., Dear, B.F., Schwencke, G., Andrews, G., Johnston, L., Craske, M.G., et al. Transdiagnostic internet treatment for anxiety and depression: a randomised controlled trial. Behav. Res. Ther. 49:8 (2011), 441–452.
46. [46] Titov, N., Andrews, G., Johnston, L., Robinson, E., Spence, J., Transdiagnostic Internet treatment for anxiety disorders: a randomized controlled trial. Behav. Res. Ther. 48:9 (2010), 890–899.
47. [47] Chan, R., Studying Psychosocial Adaptation to End-stage Renal Disease: Empirical Model Development and Evaluation. 2011, University of New South Wales, Sydney.
48. [48] Chan, R., Brooks, R., Erlich, J., Gallagher, M., Snelling, P., Chow, J., et al. How do clinical and psychological variables relate to quality of life in end-stage renal disease? Validating a proximal-distal model. Qual. Life Res. 23:2 (2014), 677–686.
49. [49] Hays, R.D., Kallich, J.D., Mapes, D.L., Coons, S.J., Carter, W.B., Development of the kidney disease quality of life (KDQOL) instrument. Qual. Life Res. 3:5 (1994), 329–338.